Загрузка...
Losartan may inhibit the progression of liver fibrosis in chronic HCV patients
BACKGROUND: Abundant experimental evidence indicates overproduction of angiotensin II in the injured liver, and a role in stimulation of hepatic stellate cell (HSC) activation and fibrogenesis thereby, representing an attractive antifibrotic target. The aim of this study was to examine the antifibro...
Сохранить в:
| Опубликовано в: : | Hepatobiliary Surg Nutr |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
AME Publishing Company
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4876242/ https://ncbi.nlm.nih.gov/pubmed/27275467 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/hbsn.2016.02.06 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|